Researchers make progress toward inhalable mRNA medicines

Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled.

Key reason why some cancers do not respond to immunotherapy identified

Research reveals SLC13A3’s role in tumor cell survival and immune therapy resistance, highlighting its potential as a target for improved cancer treatments.

November 12, 2024

BTK Inhibitor Reduces Brain Lesions in Relapsing MS

MILAN — Investigational fenebrutinib reduced brain lesions in relapsing multiple sclerosis (MS) patients and showed evidence of central nervous system (CNS) penetration, data from the

October 20, 2023

New emergency department for over 80s reduces wait times

The formation of the country’s first emergency department for the over 80s led to a significant decrease in time spent in A&E – according to

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.